|
|
|
|
| LEADER |
02952nam a22004215i 4500 |
| 001 |
978-3-319-49284-1 |
| 005 |
20191028132605.0 |
| 007 |
cr nn 008mamaa |
| 008 |
161222s2016 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319492841
|
| 024 |
7 |
|
|a 10.1007/978-3-319-49284-1
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a How to Overcome the Antibiotic Crisis
|b Facts, Challenges, Technologies and Future Perspectives /
|c edited by Marc Stadler, Petra Dersch.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a XII, 496 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Current Topics in Microbiology and Immunology,
|v 398
|
| 505 |
0 |
|
|a Tackling threats and future problems of multidrug-resistant bacteria.-Emergence and spread of antimicrobial resistance: recent insights from bacterial population genomics -- Epidemiology of Staphylococcus aureus nasal carriage patterns in the community -- Diagnostics and resistance profiling of bacterial pathogens -- Use of antibiotics and antimicrobial resistance in veterinary medicine as exemplified by the swine pathogen Streptococcus suis.-Antibiotics and the intestinal microbiome: individual responses, resilience of the ecosystem and the susceptibility to infections -- Anti-virulence strategies to target bacterial infections -- Strategies to block bacterial pathogenesis by interference with motility and chemotaxis -- New horizons in the development of novel needle-free immunization strategies to increase vaccination efficacy -- History of antibiotics research -- Actinobacteria and Myxobacteria – Two of the most important bacterial resources for novel antibiotics -- Exploitation of fungal biodiversity for discovery of novel antibiotics -- Strategies for the discovery and development of new antibiotics from natural products: Three Case Studies -- New structural templates for clinically validated and novel targets in antimicrobial drug research and development -- Synthesis of antibiotics -- Antibiotics clinical development and pipeline -- Anti-infectives in drug delivery—overcoming the Gram-negative bacterial cell envelope.
|
| 650 |
|
0 |
|a Medical microbiology.
|
| 650 |
|
0 |
|a Infectious diseases.
|
| 650 |
|
0 |
|a Bacteriology.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Medicinal chemistry.
|
| 650 |
|
0 |
|a Veterinary medicine.
|
| 650 |
1 |
4 |
|a Medical Microbiology.
|
| 650 |
2 |
4 |
|a Infectious Diseases.
|
| 650 |
2 |
4 |
|a Bacteriology.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Medicinal Chemistry.
|
| 650 |
2 |
4 |
|a Veterinary Medicine/Veterinary Science.
|
| 700 |
1 |
|
|a Stadler, Marc.
|e editor.
|
| 700 |
1 |
|
|a Dersch, Petra.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-49284-1
|